PBS News Hour

What we know about remdesivir study and COVID-19 antibodies

Testing, both for active cases of COVID-19 and for antibodies indicating prior exposure to the disease, will be critical to resuming economic activity. In addition, scientists are racing to develop therapies for people who do get infected -- especially those who become seriously ill. Science correspondent Miles O’Brien joins Judy Woodruff to discuss the latest on COVID-19 testing and treatment.

What we know about remdesivir study and COVID-19 antibodies

7m 11s

WETA Passport

Stream tens of thousands of hours of your PBS and local favorites with WETA Passport whenever and wherever you want. Catch up on a single episode or binge-watch full seasons before they air on TV.